Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A revised classification scheme for acute transfusion reactions.

Robert P Sanders1, Terrence L Geiger, Nancy Heddle

  • 1Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA. robert.sanders@stjude.org

Transfusion
|March 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author

Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome.

Blood advances·2022
Same author

Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.

Blood·2022
Same author

Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.

Nature genetics·2022
Same author

Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.

JAMA oncology·2022
Same author

Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular Care.

Children (Basel, Switzerland)·2021
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
Same journal

AABB survey on directed blood donation practices.

Transfusion·2026
Same journal

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
See all related articles

A revised classification system for acute transfusion reactions offers improved diagnostic clarity and severity grading. This new approach addresses limitations of the current standard, enhancing patient management and clinical research accuracy.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Clinical Pathology

Background:

  • Current acute transfusion reaction classification lacks strict diagnostic criteria, leading to variability.
  • This variability complicates patient management and clinical research efforts.

Purpose of the Study:

  • To develop and evaluate a revised classification system for acute transfusion reactions.
  • The system aims to refine categories, add severity grading, and improve attribution clarity.

Main Methods:

  • Reviewed 595 transfusion reactions using established AABB conventions.
  • Reclassified reactions with a revised system incorporating severity grades (CTCAE format) and attribution terminology.

Main Results:

Related Experiment Videos

  • The revised system demonstrated clear advantages over the standard classification.
  • It effectively categorized 123 of 128 previously inconclusive or mixed reactions.
  • Severity grading was readily applied to all classifiable reactions.

    • Conclusions:

    • The revised classification scheme for acute transfusion reactions shows significant advantages.
    • Prospective evaluation and potential clinical practice adoption are warranted.